These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 17190905

  • 21. Ceramide and adenosine 5'-monophosphate-activated protein kinase are two novel regulators of 11beta-hydroxysteroid dehydrogenase type 1 expression and activity in cultured preadipocytes.
    Arai N, Masuzaki H, Tanaka T, Ishii T, Yasue S, Kobayashi N, Tomita T, Noguchi M, Kusakabe T, Fujikura J, Ebihara K, Hirata M, Hosoda K, Hayashi T, Sawai H, Minokoshi Y, Nakao K.
    Endocrinology; 2007 Nov; 148(11):5268-77. PubMed ID: 17702848
    [Abstract] [Full Text] [Related]

  • 22. Antidiabetic effects of 11beta-HSD1 inhibition in a mouse model of combined diabetes, dyslipidaemia and atherosclerosis.
    Lloyd DJ, Helmering J, Cordover D, Bowsman M, Chen M, Hale C, Fordstrom P, Zhou M, Wang M, Kaufman SA, Véniant MM.
    Diabetes Obes Metab; 2009 Jul; 11(7):688-99. PubMed ID: 19527482
    [Abstract] [Full Text] [Related]

  • 23. Deep subcutaneous adipose tissue: a distinct abdominal adipose depot.
    Walker GE, Verti B, Marzullo P, Savia G, Mencarelli M, Zurleni F, Liuzzi A, Di Blasio AM.
    Obesity (Silver Spring); 2007 Aug; 15(8):1933-43. PubMed ID: 17712110
    [Abstract] [Full Text] [Related]

  • 24. Low-abundant adiponectin receptors in visceral adipose tissue of humans and rats are further reduced in diabetic animals.
    Bauer S, Weigert J, Neumeier M, Wanninger J, Schäffler A, Luchner A, Schnitzbauer AA, Aslanidis C, Buechler C.
    Arch Med Res; 2010 Feb; 41(2):75-82. PubMed ID: 20470935
    [Abstract] [Full Text] [Related]

  • 25. Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells.
    Ignatova ID, Kostadinova RM, Goldring CE, Nawrocki AR, Frey FJ, Frey BM.
    Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E367-77. PubMed ID: 19088256
    [Abstract] [Full Text] [Related]

  • 26. Anti-diabetic and anti-inflammatory effect of a novel selective 11β-HSD1 inhibitor in the diet-induced obese mice.
    Park SB, Jung WH, Kang NS, Park JS, Bae GH, Kim HY, Rhee SD, Kang SK, Ahn JH, Jeong HG, Kim KY.
    Eur J Pharmacol; 2013 Dec 05; 721(1-3):70-9. PubMed ID: 24135201
    [Abstract] [Full Text] [Related]

  • 27. Emodin, an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, regulates adipocyte function in vitro and exerts anti-diabetic effect in ob/ob mice.
    Wang YJ, Huang SL, Feng Y, Ning MM, Leng Y.
    Acta Pharmacol Sin; 2012 Sep 05; 33(9):1195-203. PubMed ID: 22922341
    [Abstract] [Full Text] [Related]

  • 28. Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro.
    Lagathu C, Bastard JP, Auclair M, Maachi M, Kornprobst M, Capeau J, Caron M.
    Antivir Ther; 2004 Dec 05; 9(6):911-20. PubMed ID: 15651750
    [Abstract] [Full Text] [Related]

  • 29. 11 beta-hydroxysteroid dehydrogenase type 1 promotes differentiation of 3T3-L1 preadipocyte.
    Liu Y, Sun Y, Zhu T, Xie Y, Yu J, Sun WL, Ding GX, Hu G.
    Acta Pharmacol Sin; 2007 Aug 05; 28(8):1198-204. PubMed ID: 17640483
    [Abstract] [Full Text] [Related]

  • 30. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
    Iwasaki Y, Takayasu S, Nishiyama M, Tsugita M, Taguchi T, Asai M, Yoshida M, Kambayashi M, Hashimoto K.
    Mol Cell Endocrinol; 2008 Mar 26; 285(1-2):10-8. PubMed ID: 18313835
    [Abstract] [Full Text] [Related]

  • 31. The environmental obesogen bisphenol A promotes adipogenesis by increasing the amount of 11β-hydroxysteroid dehydrogenase type 1 in the adipose tissue of children.
    Wang J, Sun B, Hou M, Pan X, Li X.
    Int J Obes (Lond); 2013 Jul 26; 37(7):999-1005. PubMed ID: 23090578
    [Abstract] [Full Text] [Related]

  • 32. Pharmacological evaluation of adipose dysfunction via 11β-hydroxysteroid dehydrogenase type 1 in the development of diabetes in diet-induced obese mice with cortisone pellet implantation.
    Akiyama N, Akiyama Y, Kato H, Kuroda T, Ono T, Imagawa K, Asakura K, Shinosaki T, Murayama T, Hanasaki K.
    J Pharmacol Exp Ther; 2014 Apr 26; 349(1):66-74. PubMed ID: 24511146
    [Abstract] [Full Text] [Related]

  • 33. Depot-specific messenger RNA expression of 11 beta-hydroxysteroid dehydrogenase type 1 and leptin in adipose tissue of children and adults.
    Li X, Lindquist S, Chen R, Myrnäs T, Angsten G, Olsson T, Hernell O.
    Int J Obes (Lond); 2007 May 26; 31(5):820-8. PubMed ID: 17060929
    [Abstract] [Full Text] [Related]

  • 34. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
    Stimson RH, Walker BR.
    Minerva Endocrinol; 2007 Sep 26; 32(3):141-59. PubMed ID: 17912154
    [Abstract] [Full Text] [Related]

  • 35. The functional consequences of 11beta-hydroxysteroid dehydrogenase expression in adipose tissue.
    Tomlinson JW, Stewart PM.
    Horm Metab Res; 2002 Sep 26; 34(11-12):746-51. PubMed ID: 12660893
    [Abstract] [Full Text] [Related]

  • 36. Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy.
    Wang M.
    Handb Exp Pharmacol; 2011 Sep 26; (203):127-46. PubMed ID: 21484570
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.
    Mai K, Kullmann V, Bobbert T, Maser-Gluth C, Möhlig M, Bähr V, Pfeiffer AF, Spranger J, Diederich S.
    Clin Endocrinol (Oxf); 2005 Oct 26; 63(4):442-9. PubMed ID: 16181237
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen.
    Paulsen SK, Nielsen MP, Richelsen B, Bruun JM, Flyvbjerg A, Pedersen SB.
    Obesity (Silver Spring); 2008 Apr 26; 16(4):731-5. PubMed ID: 18379559
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.